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As a basis for prioritizing the allocation
of financial and other resources targeted
for international development, the strong
preference of the global community’s
policy makers and donors is to rely on
numbers. Metrics such as DALYS (dis-
ability-adjusted life years—the number of
healthy life years lost either from death or
disability) or DALYs averted per dollar
provide highly useful information about
the cost-effectiveness of health interven-
tions in different settings. In turn, the cost-
effectiveness of a program is considered
fundamental to its merit or its need for
redesign. In this regard, one of the
important achievements of this decade is
the publication of the Second Edition of
the Disease Control Priorities in Developing
Countries. DCP-2 is a landmark document
for informing fundamental policy consid-
erations, selecting and scaling up effective
interventions, and identifying opportuni-
ties for ongoing research [1].
Among the important findings of the
DCP-2 is the great cost-effectiveness of
many interventions that target the ne-
glected tropical diseases (NTDs). For
example, at a cost of US$2–US$9 per
DALY averted for deworming (mass drug
administration for soil-transmitted hel-
minth infections) and US$4–US$9 per
DALY averted for yearly antifilarial pre-
ventive chemotherapy treatments, these
two NTD control programs are now
considered some of the better buys in
public health, compared to, for example,
US$257–US$4,565 per DALY averted for
measles vaccination (which is still a very
good buy) [2]. Global efforts to integrate
NTD control by combining interventions
in a package of antihelminthic drugs
together with azithromycin is expected to
result in additional cost savings of 26%–
47% [3], making NTD control an even
better buy [4].
In some respects, however, we have only
started to explore the true diseaseburden of
the NTDs and therefore the ultimate cost-
effectiveness of NTD interventions. For
example, Professor Charles H. King and
his colleagues have begun to incorporate
a number of additional chronic and de-
bilitating elements into their estimates of
the disease burden of schistosomiasis and
have determined that the number of
DALYs lost from this disease may far
exceed previous estimates [5,6]. Over the
next two years, an initiative sponsored by
the new Institute of Health Metrics and
Evaluation at the University of Washington
in Seattle, together with the Department of
International Health at the Johns Hopkins
Bloomberg School ofPublicHealth andthe
Global Network for Neglected Tropical
Diseases, will revisit the disease burden for
most of the NTDs [7–9].
In anticipation of renewed interest in
assessing the disease burden of the NTDs
and the cost-effectiveness of NTD inter-
ventions, PLoS Neglected Tropical Diseases will
devote a considerable amount of space
and energy to these issues. Under the
leadership of Simon Brooker and Juerg
Utzinger, in this issue of PLoS Neglected
Tropical Diseases we begin a series of articles
devoted to NTD disease burden and the
controversies about how the chronic and
disabling features of these conditions
should be best evaluated. It is hoped that
this dialogue will both help to stimulate
new interest in the NTDs and elevate their
profile among global health policy makers.
The series begins with an overview by
Colin Mathers and colleagues of the
analytic approach used by the original
Global Burden of Disease (GBD) Study,
with a particular focus on the NTDs [10].
The overview is accompanied by a pro-
vocative Viewpoint from Burton Singer
and Carol Ryff, who call for ‘‘far more
extensive revision of outcome measures
and of the entire GBD framework’’ [11].
Unfortunately, it is not always possible
to assign a number to the horrific effects of
a NTD. In recognition that there is an
almost intangible element that defies
conventional quantitative metrics, in this
issue of PLoS Neglected Tropical Diseases [13],
Myrtle Perera of the Marga Institute in Sri
Lanka, together with her colleagues at the
Universities of Liverpool and Ruhuna,
reports on an innovative effort that uses
narrative and other qualitative techniques
in order to profile the plight of Sri Lankan
people living with the effects of lymphatic
filariasis (LF). In sometimes graphic detail,
Perera et al. eloquently portray the
emotional distress and social isolation that
results from the stigma of LF, sometimes
to the point where affected patients even
avoid desperately needed services that are
freely available at government clinics.
Perera et al. also articulate how these
social elements combine in a toxic manner
that pushes LF patients into a vortex of
poverty, which is almost impossible to
escape. Their findings provide an impor-
tant qualitative complement to the pre-
vious financial estimates of Dr. K. D.
Ramaiah and his colleagues, who have
determined that LF causes more than
US$1 billion in economic losses for India
annually [14].
The Marga Institute derives its name
from a Sanskrit word that translates into
a quest for ultimate meaning or deliver-
ance from suffering [15]. The study
conducted by the Marga group is certainly
in that spirit. By highlighting how the
NTDs promote poverty, both quantita-
tively and through narrative, we at PLoS
Neglected Tropical Diseases ultimately also
aspire to provide a full and complete
picture of the sufferings of the world’s most
vulnerable at-risk populations.
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